Quick View
Loading...
Kalpa Pharmaceuticals
Estimated Delivery: 12-26 Days (International), 3-6 Days (United States)
Return within 45 Days of purchase. Duties & taxes are non-refundable.
Buy Nolvaxyl 20 mg tablets by Kalpa Pharmaceuticals at XSteroids. Nolvaxyl is tamoxifen citrate, a selective estrogen receptor modulator, and Kalpa Pharmaceuticals supplies it as 20 mg tablets in a box of 100. Further down this page: what the tablet contains, the receptor mechanics that make it useful after a course, the changes a user tracks over six weeks, how a schedule is built, how it behaves when taken during a course rather than after one, the two serious risks on its label, and how the pack should be kept.
Tamoxifen is not a supplement. The approved drug is Nolvadex, a long established prescription used in breast cancer treatment and prevention, and in that setting it is taken for years. The tablets Kalpa lists are a brand-labelled research article, not the pharmacy pack, and no independent test of their content is available. All figures below are quoted from clinical sources as orientation, and nothing here should be read as a plan to follow.
The box contains 100 tablets of 20 mg tamoxifen citrate, presented in the salt form used clinically, where 20 mg of citrate carries about 15.2 mg of the active base. Tamoxifen is a non-steroidal molecule built on a triphenylethylene backbone, and its defining characteristic is that it does not behave the same way in every tissue: in breast tissue it blocks estrogen signalling, while in bone it acts partly like estrogen itself.
For this product the paperwork is thin. Kalpa states the strength and the count; no excipient list, no batch assay and no third party potency result are published. That matters little for a molecule whose own clinical profile is well documented, but it does mean the label should be treated as a claim to be accepted or not, never as a verified fact.
The target of tamoxifen is the estrogen receptor, not the enzyme that makes estrogen. In a man the receptors that matter most for hormone output sit in the hypothalamus and the pituitary, where estradiol normally feeds back to slow the signal down. Tamoxifen occupies those receptors and breaks the feedback loop, so the hypothalamus releases more GnRH, the pituitary answers with more LH and FSH, and the testes respond by producing more testosterone of the body's own.
Two consequences follow from that distinction. First, circulating estradiol is not reduced at all: production continues and the level is whatever the aromatising load makes it, while the receptor simply does not see it. Second, the drug stays in the body for a long time. The elimination half-life is five to seven days, and the main metabolite, N-desmethyltamoxifen, clears even more slowly, so the effect persists for weeks after the final tablet.
The earliest evidence is a blood test rather than a feeling. Luteinising hormone, follicle stimulating hormone and total testosterone begin climbing within roughly one to two weeks, and the size of the rise depends on how deeply the axis was suppressed and how long the suppression lasted. Users often describe a return of morning erections, better energy and a lighter mood in the first fortnight, which matches the direction of the numbers.
Estrogen-related symptoms can appear even though production has not changed, because the receptor is blocked in some tissues and stimulated in others. Hot flushes are the common complaint, along with night sweats and occasional irritability. Strength and size do not return quickly and were never the point: tamoxifen restores the signal, while muscle is rebuilt later by training and food.
The clinical indication uses 20 mg daily, and older studies also used 10 mg twice a day; both are reference points rather than a template for a recreational course. Material on post cycle therapy generally describes 20 to 40 mg daily for four to six weeks, occasionally with a short higher front end and a step down at the finish.
Because the half-life runs five to seven days, the drug accumulates and the level is stable from roughly the first week, which is why an occasional missed tablet changes very little. The endpoint is a blood test, not a calendar: total testosterone, LH and estradiol together show whether the axis has actually restarted or merely looks restarted.
Tamoxifen can be used during a course as well as after one, and it does a very different job in that position. It does not stop estrogen from being produced - that is the work of an aromatase inhibitor such as Aromaxyl (exemestane) or Letroxyl (letrozole) - but it can hold the receptor away from estrogen that is already circulating, which is the mechanism behind its long standing use against gynecomastia.
Which of the two is appropriate depends on what the cycle is doing. An aromatising base such as Testoxyl, the Kalpa testosterone line, or an oral such as Dianoxyl, the Kalpa methandienone range, raises production and is usually handled by an inhibitor, while a stack built on Trenboxyl, the Kalpa trenbolone line, raises different problems that the receptor route suits better. Running both an inhibitor and this tablet together to cover every possibility is a common way to end up with neither effect done properly.
The course does not end when the box does. Because the half-life is measured in days and the metabolite lasts longer still, receptor blockade eases gradually after the final tablet, and the axis holds whatever level it reached. A second blood test a month later, taken after everything has cleared, tells the real story; the numbers at the end of the course are partly the drug talking.
If the axis has not restarted, the answer is usually to look at what preceded it rather than to add more tablets. Clomixyl (clomiphene) works on the same receptor group from a different angle and is the usual alternative, while Proviroxyl (mesterolone) is a support product with no effect on the pituitary at all.
Common effects are hot flushes, nausea, headache, dry skin and occasional visual disturbance, and any persistent change in vision is a reason to stop and seek advice. Less common but more serious is the thrombotic risk: long term use at high cumulative doses is linked with deep vein thrombosis and pulmonary embolism, and the risk rises with dose and duration. Changes in liver enzymes and lipids are also recorded.
Tamoxifen is a prescription medicine in most countries, and it is named in class S4 of the WADA Prohibited List as a selective estrogen receptor modulator, so it is banned at all times in sport. Research use only.
Room temperature and a dry cupboard are enough; there is no reason to chill or freeze the pack, and damp air harms tablets more than warmth does. Keep the carton away from direct sun and out of reach of children, and write the expiry date somewhere visible when the box arrives. Discard tablets that crumble, darken or stick together.
Nolvaxyl is one entry in the Kalpa Pharmaceuticals brand catalog, and XSteroids holds the whole recovery shelf beside it, so the course that suppressed the axis and the product that restarts it can be ordered together instead of in separate transactions. Payment is handled over an encrypted checkout, US deliveries usually arrive within 3 to 6 days and international parcels within 12 to 26 days. The related cards below set out the usual pairings.
Nolvaxyl supplies tamoxifen citrate, a selective estrogen receptor modulator used medically in breast cancer treatment and prevention. In a bodybuilding context the same receptor action is used after a course to help the hypothalamus and pituitary restart natural testosterone production, and during a course to keep estrogen away from receptor sites.
It blocks estrogen receptors in the hypothalamus and pituitary, which removes the negative feedback that estradiol normally provides. The brain then releases more GnRH, the pituitary more luteinising hormone and follicle stimulating hormone, and the testes answer with more testosterone of their own. Estrogen production itself is untouched throughout.
A long time by oral standards. The elimination half-life is five to seven days, and the main metabolite clears even more slowly, so meaningful blockade persists for weeks after the final tablet. That is why a follow-up blood test should be taken a month later rather than the day the course ends.
Yes, and it does a different job there. It does not reduce estrogen production, which is what an aromatase inhibitor does; it occupies the receptor so circulating estrogen cannot act at sensitive sites such as breast tissue. It is generally chosen for that purpose rather than alongside an inhibitor, since combining the two often means neither works cleanly.
Yes, and this is the risk that matters most. Long term tamoxifen therapy at high cumulative doses is associated with deep vein thrombosis and pulmonary embolism, and the likelihood grows with dose and duration. Unexplained calf pain, swelling or breathlessness during a course is a medical emergency rather than something to observe.
Yes, at all times. Tamoxifen is a selective estrogen receptor modulator and is named in class S4, Hormone and Metabolic Modulators, on the WADA Prohibited List, so it is prohibited in and out of competition. It is treated as a hormone modifying agent, and a therapeutic use exemption is unrealistic without a genuine clinical diagnosis.
You can buy Nolvaxyl 20 mg by Kalpa Pharmaceuticals online at XSteroids, direct from the brand catalog. Add the 100 tablet pack to the cart on this page and complete the encrypted checkout. Orders within the United States take 3 to 6 days, while international delivery runs 12 to 26 days.
Loading...
Your cart is currently empty. Let us assist you in finding the right product